0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Throat Cancer Therapeutics Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-37I14105
Home | Market Reports | Health| Health Conditions| Cancer
Global Throat Cancer Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Throat Cancer Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-37I14105
Report
December 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Throat Cancer Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Throat Cancer Therapeutics Market

Throat Cancer Therapeutics Market

Laryngeal cancer are mostly squamous cell carcinomas, reflecting their origin from the skin of the larynx.Oropharyngeal cancer is a disease in which cancer form in the tissues of the throat (oropharynx).
Market Analysis and Insights: Global Throat Cancer Therapeutics Market
The global Throat Cancer Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Throat Cancer Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Throat Cancer Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Throat Cancer Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Throat Cancer Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Throat Cancer Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Throat Cancer Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Throat Cancer Therapeutics Market Report

Report Metric Details
Report Name Throat Cancer Therapeutics Market
CAGR 5%
Segment by Type
  • Surgery
  • Radiotherapy
  • Chemotherapy
Segment by Application
  • Oropharyngeal Cancer
  • Laryngeal Cancer
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Throat Cancer Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Throat Cancer Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Throat Cancer Therapeutics revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Throat Cancer Therapeutics Market report?

Ans: The main players in the Throat Cancer Therapeutics Market are Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Sanofi

What are the Application segmentation covered in the Throat Cancer Therapeutics Market report?

Ans: The Applications covered in the Throat Cancer Therapeutics Market report are Oropharyngeal Cancer, Laryngeal Cancer

What are the Type segmentation covered in the Throat Cancer Therapeutics Market report?

Ans: The Types covered in the Throat Cancer Therapeutics Market report are Surgery, Radiotherapy, Chemotherapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Throat Cancer Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Surgery
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.3 Market by Application
1.3.1 Global Throat Cancer Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oropharyngeal Cancer
1.3.3 Laryngeal Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Throat Cancer Therapeutics Market Perspective (2019-2030)
2.2 Global Throat Cancer Therapeutics Growth Trends by Region
2.2.1 Throat Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Throat Cancer Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Throat Cancer Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Throat Cancer Therapeutics Market Dynamics
2.3.1 Throat Cancer Therapeutics Industry Trends
2.3.2 Throat Cancer Therapeutics Market Drivers
2.3.3 Throat Cancer Therapeutics Market Challenges
2.3.4 Throat Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Throat Cancer Therapeutics by Players
3.1.1 Global Throat Cancer Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Throat Cancer Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Throat Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Throat Cancer Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Throat Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Throat Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Throat Cancer Therapeutics Revenue in 2023
3.5 Global Key Players of Throat Cancer Therapeutics Head office and Area Served
3.6 Global Key Players of Throat Cancer Therapeutics, Product and Application
3.7 Global Key Players of Throat Cancer Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Throat Cancer Therapeutics Breakdown Data by Type
4.1 Global Throat Cancer Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Throat Cancer Therapeutics Forecasted Market Size by Type (2025-2030)
5 Throat Cancer Therapeutics Breakdown Data by Application
5.1 Global Throat Cancer Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Throat Cancer Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Throat Cancer Therapeutics Market Size (2019-2030)
6.2 North America Throat Cancer Therapeutics Market Size by Type
6.2.1 North America Throat Cancer Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Throat Cancer Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Throat Cancer Therapeutics Market Share by Type (2019-2030)
6.3 North America Throat Cancer Therapeutics Market Size by Application
6.3.1 North America Throat Cancer Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Throat Cancer Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Throat Cancer Therapeutics Market Share by Application (2019-2030)
6.4 North America Throat Cancer Therapeutics Market Size by Country
6.4.1 North America Throat Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Throat Cancer Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Throat Cancer Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Throat Cancer Therapeutics Market Size (2019-2030)
7.2 Europe Throat Cancer Therapeutics Market Size by Type
7.2.1 Europe Throat Cancer Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Throat Cancer Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Throat Cancer Therapeutics Market Share by Type (2019-2030)
7.3 Europe Throat Cancer Therapeutics Market Size by Application
7.3.1 Europe Throat Cancer Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Throat Cancer Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Throat Cancer Therapeutics Market Share by Application (2019-2030)
7.4 Europe Throat Cancer Therapeutics Market Size by Country
7.4.1 Europe Throat Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Throat Cancer Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Throat Cancer Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Throat Cancer Therapeutics Market Size (2019-2030)
8.2 China Throat Cancer Therapeutics Market Size by Type
8.2.1 China Throat Cancer Therapeutics Market Size by Type (2019-2024)
8.2.2 China Throat Cancer Therapeutics Market Size by Type (2025-2030)
8.2.3 China Throat Cancer Therapeutics Market Share by Type (2019-2030)
8.3 China Throat Cancer Therapeutics Market Size by Application
8.3.1 China Throat Cancer Therapeutics Market Size by Application (2019-2024)
8.3.2 China Throat Cancer Therapeutics Market Size by Application (2025-2030)
8.3.3 China Throat Cancer Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Throat Cancer Therapeutics Market Size (2019-2030)
9.2 Asia Throat Cancer Therapeutics Market Size by Type
9.2.1 Asia Throat Cancer Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Throat Cancer Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Throat Cancer Therapeutics Market Share by Type (2019-2030)
9.3 Asia Throat Cancer Therapeutics Market Size by Application
9.3.1 Asia Throat Cancer Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Throat Cancer Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Throat Cancer Therapeutics Market Share by Application (2019-2030)
9.4 Asia Throat Cancer Therapeutics Market Size by Region
9.4.1 Asia Throat Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Throat Cancer Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Throat Cancer Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bristol-Myers Squibb Co.
11.1.1 Bristol-Myers Squibb Co. Company Details
11.1.2 Bristol-Myers Squibb Co. Business Overview
11.1.3 Bristol-Myers Squibb Co. Throat Cancer Therapeutics Introduction
11.1.4 Bristol-Myers Squibb Co. Revenue in Throat Cancer Therapeutics Business (2019-2024)
11.1.5 Bristol-Myers Squibb Co. Recent Developments
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Details
11.2.2 Eli Lilly and Co. Business Overview
11.2.3 Eli Lilly and Co. Throat Cancer Therapeutics Introduction
11.2.4 Eli Lilly and Co. Revenue in Throat Cancer Therapeutics Business (2019-2024)
11.2.5 Eli Lilly and Co. Recent Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Throat Cancer Therapeutics Business (2019-2024)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Throat Cancer Therapeutics Introduction
11.4.4 Merck & Co., Inc. Revenue in Throat Cancer Therapeutics Business (2019-2024)
11.4.5 Merck & Co., Inc. Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Throat Cancer Therapeutics Introduction
11.5.4 Sanofi Revenue in Throat Cancer Therapeutics Business (2019-2024)
11.5.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Throat Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Surgery
    Table 3. Key Players of Radiotherapy
    Table 4. Key Players of Chemotherapy
    Table 5. Global Throat Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Throat Cancer Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Throat Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Throat Cancer Therapeutics Market Share by Region (2019-2024)
    Table 9. Global Throat Cancer Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Throat Cancer Therapeutics Market Share by Region (2025-2030)
    Table 11. Throat Cancer Therapeutics Market Trends
    Table 12. Throat Cancer Therapeutics Market Drivers
    Table 13. Throat Cancer Therapeutics Market Challenges
    Table 14. Throat Cancer Therapeutics Market Restraints
    Table 15. Global Throat Cancer Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Throat Cancer Therapeutics Revenue Share by Players (2019-2024)
    Table 17. Global Top Throat Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Throat Cancer Therapeutics as of 2023)
    Table 18. Global Throat Cancer Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Throat Cancer Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Throat Cancer Therapeutics, Headquarters and Area Served
    Table 21. Global Key Players of Throat Cancer Therapeutics, Product and Application
    Table 22. Global Key Players of Throat Cancer Therapeutics, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Throat Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Throat Cancer Therapeutics Revenue Market Share by Type (2019-2024)
    Table 26. Global Throat Cancer Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Throat Cancer Therapeutics Revenue Market Share by Type (2025-2030)
    Table 28. Global Throat Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Throat Cancer Therapeutics Revenue Share by Application (2019-2024)
    Table 30. Global Throat Cancer Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Throat Cancer Therapeutics Revenue Share by Application (2025-2030)
    Table 32. North America Throat Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Throat Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Throat Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Throat Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Throat Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Throat Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Throat Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Throat Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Throat Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Throat Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Throat Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Throat Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Throat Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Throat Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Throat Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Throat Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Throat Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Throat Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Throat Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Throat Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Throat Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Throat Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Throat Cancer Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Throat Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Throat Cancer Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Throat Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Bristol-Myers Squibb Co. Company Details
    Table 65. Bristol-Myers Squibb Co. Business Overview
    Table 66. Bristol-Myers Squibb Co. Throat Cancer Therapeutics Product
    Table 67. Bristol-Myers Squibb Co. Revenue in Throat Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 68. Bristol-Myers Squibb Co. Recent Developments
    Table 69. Eli Lilly and Co. Company Details
    Table 70. Eli Lilly and Co. Business Overview
    Table 71. Eli Lilly and Co. Throat Cancer Therapeutics Product
    Table 72. Eli Lilly and Co. Revenue in Throat Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 73. Eli Lilly and Co. Recent Developments
    Table 74. F. Hoffmann-La Roche Ltd. Company Details
    Table 75. F. Hoffmann-La Roche Ltd. Business Overview
    Table 76. F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Product
    Table 77. F. Hoffmann-La Roche Ltd. Revenue in Throat Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 78. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 79. Merck & Co., Inc. Company Details
    Table 80. Merck & Co., Inc. Business Overview
    Table 81. Merck & Co., Inc. Throat Cancer Therapeutics Product
    Table 82. Merck & Co., Inc. Revenue in Throat Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 83. Merck & Co., Inc. Recent Developments
    Table 84. Sanofi Company Details
    Table 85. Sanofi Business Overview
    Table 86. Sanofi Throat Cancer Therapeutics Product
    Table 87. Sanofi Revenue in Throat Cancer Therapeutics Business (2019-2024) & (US$ Million)
    Table 88. Sanofi Recent Developments
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Throat Cancer Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Throat Cancer Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Surgery Features
    Figure 4. Radiotherapy Features
    Figure 5. Chemotherapy Features
    Figure 6. Global Throat Cancer Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Throat Cancer Therapeutics Market Share by Application: 2023 VS 2030
    Figure 8. Oropharyngeal Cancer Case Studies
    Figure 9. Laryngeal Cancer Case Studies
    Figure 10. Throat Cancer Therapeutics Report Years Considered
    Figure 11. Global Throat Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Throat Cancer Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Throat Cancer Therapeutics Market Share by Region: 2023 VS 2030
    Figure 14. Global Throat Cancer Therapeutics Market Share by Players in 2023
    Figure 15. Global Top Throat Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Throat Cancer Therapeutics as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Throat Cancer Therapeutics Revenue in 2023
    Figure 17. North America Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Throat Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 19. North America Throat Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 20. North America Throat Cancer Therapeutics Market Share by Country (2019-2030)
    Figure 21. United States Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Throat Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Throat Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 25. Europe Throat Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 26. Europe Throat Cancer Therapeutics Market Share by Country (2019-2030)
    Figure 27. Germany Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Throat Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Throat Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 35. China Throat Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 36. Asia Throat Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Throat Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 38. Asia Throat Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 39. Asia Throat Cancer Therapeutics Market Share by Region (2019-2030)
    Figure 40. Japan Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Throat Cancer Therapeutics Market Share by Country (2019-2030)
    Figure 50. Brazil Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Throat Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Bristol-Myers Squibb Co. Revenue Growth Rate in Throat Cancer Therapeutics Business (2019-2024)
    Figure 57. Eli Lilly and Co. Revenue Growth Rate in Throat Cancer Therapeutics Business (2019-2024)
    Figure 58. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Throat Cancer Therapeutics Business (2019-2024)
    Figure 59. Merck & Co., Inc. Revenue Growth Rate in Throat Cancer Therapeutics Business (2019-2024)
    Figure 60. Sanofi Revenue Growth Rate in Throat Cancer Therapeutics Business (2019-2024)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Primary Biliary Cholangitis Therapeutics Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-11W14373
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Hurthle Cell Carcinoma Treatment Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-35B1140
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Anaplastic Large Cell Lymphoma Drugs Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-27H888
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Anaplastic Large Cell Lymphoma Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-16R5994
Fri Dec 27 00:00:00 UTC 2024

Add to Cart